TL8-14730-46482 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2021-01-09
Registered in v-safe
2021-01-09
Dose 2 — Pfizer-BioNTech
2021-01-09
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-10
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache · Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-23
Survey response — day 14, dose 2
MedDRA: Headache — Feeling: Good

Free text: More frequent headaches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-10
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-09
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-04-12
Dose 3 — Pfizer-BioNTech
2022-04-20
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-05-24
Survey response — day 42, dose 3
MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Tested positive for COVID

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Report sent to call center — day 42, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-05-25
Call 1 — Left Voicemail
2022-07-12
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-09	Pfizer-BioNTech
3	2022-04-12	Pfizer-BioNTech	No

Call center

4 call center cases

1 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 0, dose 2

2021-01-09

Systemic reaction (other): Dizziness

Release 2 — day 14, dose 2

2021-01-23

Symptoms: More frequent headaches

Release 11 — day 42, dose 3

2022-05-24

Symptoms: Tested positive for COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	✓	✓	✓
SD	SARS-CoV-2 test positive	·	·	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release